about
Natural products from microbes associated with insectsEndless Resistance. Endless Antibiotics?Current approaches to exploit actinomycetes as a source of novel natural products.Antibiotics and bacterial resistance in the 21st century.Antibacterial compounds from marine Vibrionaceae isolated on a global expedition.Microbial genomics and infectious diseases.Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolomeSubinhibitory antibiotic concentrations mediate nutrient use and competition among soil streptomyces.Production of bioactive secondary metabolites by marine vibrionaceae.The differential view of genotype-phenotype relationships.Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases worldMechanisms of resistance in bacteria: an evolutionary approachProduction and characterization of a new antibacterial peptide obtained from Aeribacillus pallidus SAT4From hormones to secondary metabolism: the emergence of metabolic gene clusters in plants.Chitin stimulates production of the antibiotic andrimid in a Vibrio coralliilyticus strain.A high-resolution LC-MS-based secondary metabolite fingerprint database of marine bacteria.Andrimid production at low temperature by a psychrotolerant Serratia proteamaculans strain.Genome sequence analysis of strain VG4 and its potential for the synthesis of antimicrobial metabolites
P2860
Q28072186-3BE3E065-F11D-454E-8599-663EFDF955B7Q28822179-320DAAAF-CCD5-4417-AC6E-FB759D945B93Q33712859-562A8378-CCE4-4914-AF0D-A31575D227CDQ34156349-9B5613FF-F126-40FC-A4EB-AD7AE8AE378CQ34576127-E9528AF1-3F84-4554-8A99-1296D5FA9F49Q34631250-3612EB6E-62FD-4104-996B-AE601E4C8AE3Q34959567-6B82B6E4-B783-41BF-8F26-E43094EA6FE0Q35067398-398EFA7E-674C-4347-902F-D7DAF2197D01Q35578322-C497223C-9E35-4242-88CE-73D27A05A318Q35623139-E063D165-F176-402E-A923-6127576236B1Q36376200-8E3FC2DA-2843-495A-921A-8184E384DE5CQ36595848-15FC0925-4BE2-4AE5-9FD7-9B7154A188C1Q36733020-484D61DD-FC5F-417D-BC9F-1B9225416F61Q37166928-A77D7929-4C11-45CA-9C3F-E024F1AA9AD0Q37858621-058F14CA-9AAC-407C-93E1-E8FC55104096Q39592287-A75D4623-61CA-4A04-B58C-E6110FDDD431Q42293014-798626E5-EB09-4E5E-A5A9-E81D1A973559Q43819408-5F7E292A-0F31-4B39-8E47-B5F1472688EFQ58704910-B53B6AB2-6CA3-474C-8F45-C5B957E5B9EE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibiotics from microbes: converging to kill.
@en
Antibiotics from microbes: converging to kill.
@nl
type
label
Antibiotics from microbes: converging to kill.
@en
Antibiotics from microbes: converging to kill.
@nl
prefLabel
Antibiotics from microbes: converging to kill.
@en
Antibiotics from microbes: converging to kill.
@nl
P2860
P1476
Antibiotics from microbes: converging to kill
@en
P2093
Michael A Fischbach
P2860
P304
P356
10.1016/J.MIB.2009.07.002
P577
2009-08-18T00:00:00Z